Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-16-138125
Filing Date
2016-12-06
Accepted
2016-12-06 16:18:32
Documents
23
Period of Report
2016-12-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v454532_6k.htm 6-K 13416
2 EXHIBIT 99.1 v454532_ex99-1.htm EX-99.1 26123
3 GRAPHIC image_001.jpg GRAPHIC 35339
4 GRAPHIC image_002.jpg GRAPHIC 283330
5 GRAPHIC image_003.jpg GRAPHIC 56182
6 GRAPHIC image_004.jpg GRAPHIC 145216
7 GRAPHIC image_005.jpg GRAPHIC 76201
8 GRAPHIC image_006.jpg GRAPHIC 118598
9 GRAPHIC image_007.jpg GRAPHIC 100276
10 GRAPHIC image_008.jpg GRAPHIC 91175
11 GRAPHIC image_009.jpg GRAPHIC 113299
12 GRAPHIC image_010.jpg GRAPHIC 129235
13 GRAPHIC image_011.jpg GRAPHIC 100776
14 GRAPHIC image_012.jpg GRAPHIC 58928
15 GRAPHIC image_013.jpg GRAPHIC 97908
16 GRAPHIC image_014.jpg GRAPHIC 117379
17 GRAPHIC image_015.jpg GRAPHIC 101330
18 GRAPHIC image_016.jpg GRAPHIC 125764
19 GRAPHIC image_017.jpg GRAPHIC 101318
20 GRAPHIC image_018.jpg GRAPHIC 109932
21 GRAPHIC image_019.jpg GRAPHIC 109945
22 GRAPHIC image_020.jpg GRAPHIC 25539
23 GRAPHIC image_021.jpg GRAPHIC 35339
  Complete submission text file 0001144204-16-138125.txt   2980749
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 162036508
SIC: 2834 Pharmaceutical Preparations